标题
Predicting treatment response to IL6R blockers in rheumatoid arthritis
作者
关键词
-
出版物
RHEUMATOLOGY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-07-31
DOI
10.1093/rheumatology/keaa529
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
- (2019) Elizabeth M A Hensor et al. RHEUMATOLOGY
- Association of serum Tocilizumab trough concentrations with clinical disease activity index scores in adult rheumatoid arthritis patients.
- (2019) Uri Arad et al. JOURNAL OF RHEUMATOLOGY
- Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
- (2018) Siddharth Singh et al. PLoS One
- Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission
- (2018) Shinya Tasaki et al. Nature Communications
- Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis
- (2018) Jonathan Massey et al. PHARMACOGENOMICS JOURNAL
- Prediction of Response to Targeted Treatment in Rheumatoid Arthritis
- (2017) C.A. Wijbrandts et al. MAYO CLINIC PROCEEDINGS
- Tocilizumab treatment leads to improvement in disease activity regardless of CCP status in rheumatoid arthritis
- (2017) Laura C. Cappelli et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register
- (2017) James M. Gwinnutt et al. Arthritis & Rheumatology
- High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort
- (2016) Meghna Jani et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study
- (2016) Yuan An et al. CLINICAL RHEUMATOLOGY
- Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis
- (2016) Mar Maldonado-Montoro et al. PHARMACOLOGICAL RESEARCH
- Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice
- (2016) Javier Narváez et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
- (2015) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis
- (2015) Meghna Jani et al. LANCET
- Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study
- (2015) Tadashi Okano et al. RHEUMATOLOGY INTERNATIONAL
- Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab
- (2015) Shintaro Hirata et al. ARTHRITIS RESEARCH & THERAPY
- Pretreatment Prediction of Individual Rheumatoid Arthritis Patients’ Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers
- (2015) Kazuko Uno et al. PLoS One
- AB0037 Evaluation of the binding kinetics and functional bioassay activity of sarilumab and tocilizumab to the human il-6 receptor (il-6r) alpha
- (2014) A. Rafique et al. ANNALS OF THE RHEUMATIC DISEASES
- FRI0007 Prediction of Therapeutic Responses to TOCILIZUMAB in Patients with Rheumatoid Arthritis Using Biomarkers Identified by Genome-Wide DNA Microarray Analysis in Peripheral Blood Mononuclear Cells
- (2014) Y. Sanayama et al. ANNALS OF THE RHEUMATIC DISEASES
- AB0453 Response to TOCILIZUMAB in Rheumatoid Arthritis is not Influenced by the Body Mass Index of the Patient
- (2014) Y.-M. Pers et al. ANNALS OF THE RHEUMATIC DISEASES
- High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis
- (2014) Anaïs Gardette et al. JOINT BONE SPINE
- Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort
- (2014) James Bluett et al. RHEUMATOLOGY
- High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis
- (2014) C. I. Daien et al. RHEUMATOLOGY
- Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
- (2014) Glynn Dennis et al. ARTHRITIS RESEARCH & THERAPY
- Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
- (2013) Tom W J Huizinga et al. ANNALS OF THE RHEUMATIC DISEASES
- Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy
- (2013) Naoshi Nishina et al. ANNALS OF THE RHEUMATIC DISEASES
- Genetics of rheumatoid arthritis contributes to biology and drug discovery
- (2013) Yukinori Okada et al. NATURE
- Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
- (2013) Yves-Marie Pers et al. RHEUMATOLOGY
- Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis
- (2013) R.J. Maneiro et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Impact of Psychological Factors on Subjective Disease Activity Assessments in Patients With Severe Rheumatoid Arthritis
- (2013) Lis Cordingley et al. ARTHRITIS CARE & RESEARCH
- IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis
- (2013) Jianmei Wang et al. BMJ Open
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis
- (2012) J Wang et al. PHARMACOGENOMICS JOURNAL
- Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
- (2011) Yusuf Yazici et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
- (2010) G. R. Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
- (2008) C Potter et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
- (2008) N Nishimoto et al. ANNALS OF THE RHEUMATIC DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started